Cite

HARVARD Citation

    Peverelle, M. et al. (2020). Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases. 26 (5), p. . [Online]. 
  
Back to record